Kratom, extracted from the leaves of a Southeast Asian tree, has expanded from traditional powders and capsules into ready-to-drink formats such as seltzers, teas, and tonics. These products market energy and mood support alongside alcohol-free options for social settings. A 2025 analysis examined more than one hundred such beverages sold online, each containing between 20 and 500 milligrams of kratom per serving. Recent manufacturing investments signal continued commercial interest even as federal regulators maintain longstanding objections.
From Tree Leaf to Canned Product
The botanical source is Mitragyna speciosa, a tropical evergreen whose leaves contain alkaloids including mitragynine. Producers have incorporated extracts into familiar retail formats that promise functional benefits without the need for preparation. Burma Brewing, based in Florida, announced expanded capacity in October for kratom alongside other botanicals and cannabinoids in beverage lines. This shift reflects broader experimentation with plant-derived ingredients in the functional-drink category. Retail availability has grown through both physical stores and online channels. The move places kratom in everyday settings such as convenience outlets and grocery coolers. Consumers encounter the ingredient in products positioned for daily use rather than niche supplement aisles. Production scaling suggests manufacturers see sustained demand despite the regulatory environment.
FDA Position and Enforcement Realities
The Food and Drug Administration has determined that kratom lacks authorization as a food additive and does not qualify as generally recognized as safe. Products containing the ingredient are therefore classified as adulterated under federal law. Warning letters have been issued to sellers, and an import alert permits detention of certain kratom dietary supplements and bulk material without inspection. Enforcement faces practical limits because supply chains involve many small or new entrants. Attorney Rajendra Persaud noted that fragmented networks of manufacturers, distributors, and retailers allow some items to reach shelves before restrictions take effect. Availability alone does not confirm safety or legal compliance, he added. Another attorney, Parham Nikfarjam, described the situation as a recurring challenge of consistency when new companies appear regularly.
Recent Events and Key Distinctions
Attention intensified after the September deaths of two University of Mississippi students. Court records indicated the presence of synthetic kratom-related compounds in products linked to the cases. Toxicology findings included mitragynine along with MGM-15 and mitragynine pseudoindoxyl. The DEA placed MGM-15, MGM-16, and mitragynine pseudoindoxyl into Schedule I effective August 26. Defense statements during an October hearing attributed one death to multiple substances including cough syrup and the other to inhalation asphyxiation. Officials have separately highlighted concerns over concentrated or enhanced 7-hydroxymitragynine products. Trace levels of this compound occur naturally in kratom, yet agency warnings target added or elevated amounts rather than the botanical material itself.
Industry Views on Consistency and Consumer Perception
Neuroscientist Jamey Maniscalco observed that standardizing mitragynine content does not automatically ensure uniform effects when other active compounds vary. Achieving reliable servings requires significant behind-the-scenes control, he said. Attorney Parham Nikfarjam pointed out that placement in familiar retail locations can create an impression of verified safety that may not exist. The category continues to draw investment even as regulators and legal experts highlight gaps between rules and market activity. Manufacturers must navigate both federal objections and the technical demands of consistent formulation. Distributors and retailers operate within a landscape where new entrants can appear quickly.
Looking Ahead for Plant-Based Functional Drinks
Kratom’s presence in beverages illustrates tensions between innovation with botanical ingredients and established food-additive requirements. Stakeholders across production, distribution, and oversight continue to operate under these constraints. The outcome will depend on how enforcement resources align with the pace of new product introductions.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.